ProShares Trust

11/19/2026 | Press release | Distributed by Public on 11/19/2026 12:25

Summary Prospectus by Investment Company (Form 497K)

 
SUMMARY PROSPECTUS
November 6, 2026, as supplemented through November 19, 2026 
 
UltraShort Anthropic
This Summary Prospectus is designed to provide investors with key fund information in a clear and concise format. Before you invest, you may want to review the Fund's Full Prospectus, which contains more information about the Fund and its risks. The Fund's Full Prospectus, dated November 6, 2026, as supplemented through November 19, 2026, and Statement of Additional Information, dated November 6, 2026, as supplemented through November 19, 2026, and as each hereafter may be supplemented, are incorporated by reference into this Summary Prospectus. All of this information may be obtained at no cost either: online at ProShares.com/fund-documents; by calling 866-PRO-5125 (866-776-5125); or by sending an email request to [email protected]. The Securities and Exchange Commission has not approved or disapproved these securities or passed upon the adequacy of this Summary Prospectus. Any representation to the contrary is a criminal offense.
  ANTY LISTED ON NASDAQ 
Receive investor materials electronically:
Shareholders may sign up for electronic delivery of investor materials. By doing so, you will receive the information faster and help us reduce the impact on the environment of providing these materials. To enroll in electronic delivery,
1.
Go to www.icsdelivery.com
2.
Select the first letter of your brokerage firm's name.
3.
From the list that follows, select your brokerage firm. If your brokerage firm is not listed, electronic delivery may not be available. Please contact your brokerage firm.
4.
Complete the information requested, including the e-mail address where you would like to receive notifications for electronic documents.
Your information will be kept confidential and will not be used for any purpose other than electronic delivery. If you change your mind, you can cancel electronic delivery at any time and revert to physical delivery of your materials. Just go to www.icsdelivery.com, perform the first three steps above, and follow the instructions for cancelling electronic delivery. If you have any questions, please contact your brokerage firm.
   UltraShort Anthropic :: 3
PROSHARES.COM
 
Investment Objective
ProShares UltraShort Anthropic (the "Fund") seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of Class A common stock of Anthropic, PBC (NASDAQ: ANT).
Important Information About the Fund
If the Fund is successful in meeting its investment objective, it should gain approximately two times as much as ANT loses when ANT falls on a given day. Conversely, it should lose approximately two times as much as ANT gains when ANT rises on a given day. The Fund does not seek to achieve two times the inverse (-2x) of the daily performance of ANT (the "Daily Target") for any period other than a day.
While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe doing so is consistent with your goals and risk tolerance. If you hold fund shares for any period other than a day, it is important for you to understand that over your holding period:
●Your return may be higher or lower than the Daily Target, and this difference may be significant.
●Factors that contribute to returns that are worse than the Daily Target include smaller ANT gains or losses and higher ANT volatility, as well as longer holding periods when these factors apply.
●Factors that contribute to returns that are better than the Daily Target include larger ANT gains or losses and lower ANT volatility, as well as longer holding periods when these factors apply.
●The more extreme these factors are, and the more they occur together, the more your return will tend to deviate from the Daily Target.
Fees and Expenses of the Fund
The table below describes the fees and expenses that you may pay if you buy, hold, and sell shares of the Fund. You may pay other fees, such as brokerage commissions and other fees to financial intermediaries, which are not reflected in the tables and examples below. 
Annual Fund Operating Expenses
(expenses that you pay each year as a percentage
of the value of your investment)
Management Fees
0.75%
Other Expenses1
0.29%
Total Annual Fund Operating Expenses Before Fee
Waivers and Expense Reimbursements
1.04%
Fee Waiver/Reimbursement2
-0.09%
Total Annual Fund Operating Expenses After Fee
Waivers and Expense Reimbursements
0.95%
1
"Other Expenses" are estimated.
2
ProShare Advisors LLC ("ProShare Advisors") has agreed to waive fees and to reimburse expenses to the extent Total Annual Fund Operating Expenses Before Fee Waivers and Expense Reimbursements, as a percentage of average daily net assets, exceed 0.95%
through September 30, 2028. Amounts waived or reimbursed in a particular contractual period may be recouped by ProShare Advisors within five years subject to certain limitations. This agreement may not be terminated before that date without the approval of the Fund's Board.
Example: This example is intended to help you compare the cost of investing in the Fund with the cost of investing in other funds.
The example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem or hold all of your shares at the end of each period. The example also assumes that your investment has a 5% return each year and that the Fund's operating expenses remain the same, except that the fee waiver/expense reimbursement is assumed only to pertain to the first year. Although your actual costs may be higher or lower, based on these assumptions your approximate costs would be: 
1 Year
3 Years
$97
$322
The Fund pays transaction and financing costs associated with the purchase and sale of securities and derivatives. These costs are not reflected in the table or the example above but are expected to be significant and to have a significant negative impact on the performance of the Fund.
Portfolio Turnover
The Fund pays transaction costs, such as commissions, when it buys and sells securities (or "turns over" its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when the Fund's shares are held in a taxable account. These costs, which are not reflected in Annual Fund Operating Expenses or in the example above, affect the Fund's performance. Because the Fund is newly organized, portfolio turnover information is not yet available.
Principal Investment Strategies
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
Anthropic, PBC ("Anthropic") develops artificial intelligence ("AI") models, including its Claude family of models, and provides related AI platforms and applications to individuals, developers, and organizations. Anthropic offers its products directly and through third-party cloud providers.
This prospectus relates only to the Fund shares offered hereby and is not a prospectus for the common stock or other securities of ANT. The Fund, ProShares Trust and ProShare Advisors are not affiliated with ANT.
ANT is registered under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Anthropic, PBC is subject to the informational requirements of the Exchange Act and files reports and other information with the Securities and Exchange Commission. Information provided to or filed with the Securities and Exchange Commission by ANT, pursuant to
4 :: UltraShort Anthropic    
PROSHARES.COM
the Exchange Act, can be located by reference to the Securities and Exchange Commission file number 333-299633 through the Securities and Exchange Commission's website at www.sec.gov. This information includes reports, proxy and information statements and other information regarding ANT and Anthropic, PBC. In addition, information regarding Anthropic, PBC may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents.
The Fund has derived all disclosures contained in this prospectus regarding Anthropic, PBC from the publicly available documents described above. Neither the Fund, the Trust, the Adviser nor any affiliate has participated in the preparation of such documents. Neither the Fund, the Trust, the Adviser nor any affiliate makes any representation that such publicly available documents or any other publicly available information regarding Anthropic, PBC is accurate or complete. ANT commenced its initial public offering on November 19, 2026. Consequently, public information about the company's operating history is limited. Furthermore, the Fund cannot give any assurance that all events occurring prior to the date of the prospectus (including events that would affect the accuracy or completeness of the publicly available documents described above) that would affect the trading price of ANT have been publicly disclosed. Subsequent disclosure of any such events or the disclosure of, or failure to disclose, material future events concerning Anthropic, PBC could affect the value of the Fund's investments with respect to ANT and therefore the value of the Fund.
Under normal circumstances, the Fund will invest at least 80% of the Fund's assets in, or provide exposure to, financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
The Fund will invest principally in the financial instruments listed below.
●ANT - The Fund may invest in ANT.
●Derivatives - Financial instruments whose value is derived from the value of an underlying asset or rate, such as stocks, bonds, exchange-traded funds, interest rates or indexes. The Fund invests in derivatives (e.g. swap agreements) in order to gain inverse leveraged exposure to ANT. These derivatives principally include:
○Swap Agreements - Contracts entered into primarily with major global financial institutions for a specified period ranging from a day to more than one year. In a standard "swap" transaction, two parties agree to exchange the return (or differentials in rates of return) earned or realized on particular predetermined investments or instruments. The gross return to be exchanged or "swapped" between the parties is calculated with respect to a "notional amount," e.g., the return on or change in value of a particular dollar amount invested in ANT.
●Money Market Instruments - The Fund expects that any cash balances maintained in connection with its use of deriva
tives will typically be held in high quality, short-term money market instruments, for example:
○U.S. Treasury Bills - U.S. government securities that have initial maturities of one year or less, and are supported by the full faith and credit of the U.S. government.
○Repurchase Agreements - Contracts in which a seller of securities, usually U.S. government securities or other money market instruments, agrees to buy the securities back at a specified time and price.
○Money Market ETF - An exchange-traded money market fund managed by ProShare Advisors that holds U.S. Treasury bills, notes, or bonds.
ProShare Advisors uses a mathematical approach to investing in which it determines the type, quantity and mix of investment positions that it believes, in combination, the Fund should hold to produce daily returns consistent with the Daily Target. For these purposes a day is measured from the time of one net asset value ("NAV") calculation to the next.
The Fund generally seeks to remain fully invested at all times in financial instruments that, in combination, provide inverse leveraged exposure consistent with the investment objective, without regard to market conditions, trends or direction.
The Fund seeks to rebalance its portfolio each day so that its exposure to ANT is consistent with the Daily Target. ANT's movements during the day will affect whether the Fund's portfolio needs to be rebalanced. For example, if ANT has risen on a given day, net assets of the Fund should fall (assuming there were no Creation Unit redemptions). As a result, the Fund's exposure will need to be decreased. Conversely, if ANT has fallen on a given day, net assets of the Fund should rise (assuming there were no Creation Units issued). As a result, the Fund's exposure will need to be increased.
Please see "Investment Objectives, Principal Investment Strategies and Related Risks" in the Fund's Prospectus for additional details.
Principal Risks
You could lose money by investing in the Fund.
●ANT Investing Risk - The Fund's performance depends on the performance of ANT. Investments in ANT and consequently investments in the Fund involve a high degree of risk. The price of ANT shares can be affected by a number of factors. Anthropic operates in a rapidly changing and highly competitive industry. Returns depend in part on Anthropic's ability to develop and commercialize advanced and competitive artificial intelligence models, sustain customer demand, and manage substantial research, development, and computing infrastructure costs. Anthropic relies on specialized hardware and a limited number of cloud service providers and suppliers, some of which are also strategic partners, investors, or customers, and capacity constraints, failure to allocate computing resources effectively, supply limitations, or conflicts of interest could adversely affect
   UltraShort Anthropic :: 5
PROSHARES.COM
its operations. Anthropic depends on its co-founders, senior management, and technical employees, and the loss of key personnel or inability to maintain its company culture could adversely affect its business. The actions, decisions, misconduct or loss of key executives could materially adversely impact Anthropic and ANT.
A substantial portion of Anthropic's revenue and accounts receivable is attributable to a limited number of customers and distribution channels, and reduced customer spending or disruptions to those channels could adversely affect financial results. Anthropic's artificial intelligence models have behaved, and may in the future behave, in unintended, misaligned, or autonomous ways. Such behavior, misuse of its models, or failures of safeguards could result in reputational harm, litigation, or regulatory action, and contractual protections and insurance may be insufficient to cover resulting liabilities and costs. Anthropic is subject to an evolving regulatory and political environment, which could increase costs, restrict operations, or reduce demand. It also faces risks related to its limited operating history, slower-than-expected market development or declining demand, and ability to sustain or reliably forecast future revenue growth.
Anthropic's governance structure concentrates voting power with its Long-Term Benefit Trust and Founder LLC disproportionately to their economic interests, which may substantially limit or eliminate public shareholders' influence over important decisions, including changes in control. ANT is incorporated as a public benefit corporation under Delaware law. Its public benefit corporation obligations require balancing shareholders' financial interests with those of other stakeholders and its stated public benefit purpose, which may conflict with shareholders' financial interests and adversely affect business performance. There is a limited body of law interpreting the governance of public benefit corporations, presenting a heightened risk of related litigation.
As ANT may have limited or no trading history, it is uncertain how they will trade in response to company-specific events, changes in macroeconomic conditions, or periods of abnormal volatility. As a result, ANT may experience significant and unexpected price fluctuations. Any of these factors may materially and adversely impact the price of ANT shares, increase the volatility of an investment in ANT and have a negative impact on the performance of the Fund.
●IPO Risk - Anthropic, PBC commenced its IPO on November 19, 2026. The market value of shares issued in an IPO may fluctuate considerably due to factors such as the absence of a prior public market, unseasoned trading, the limited number of shares available for trading and limited information about a company's business model, quality of management, earnings growth potential, and other criteria used to evaluate its investment prospects. Shares offered in an IPO may trade at prices that are below the initial public
offering price. Accordingly, investments in shares of a company that recently commenced an IPO can involve greater risks than investments in shares of companies that have traded publicly on an exchange for extended periods of time. Investments in shares of a company that recently commenced an IPO may also involve high transaction costs and are subject to market risk and liquidity risk. Immediately following its IPO, ANT may experience abnormal returns and volatility. Such returns should not be expected to persist. The price of ANT could continue to be volatile and could decline in value significantly in the future. Although there can be no guarantee that the Fund will achieve its investment objective on any particular day, there is heightened risk that the Fund will not operate as intended immediately following the IPO and for a period of time thereafter.
●Leverage Risk - The Fund uses leverage and will lose more money when the value of ANT rises than a similar fund that does not use leverage because leverage will magnify the performance of ANT. The use of such leverage increases the risk of a total loss of your investment. If ANT approaches a 50% gain at any point in the day, you could lose your entire investment. Such losses are more likely in ANT than in other more diversified investments. As a result, an investment in the Fund may not be suitable for all investors. The use of leverage increases the volatility of your returns. The cost of obtaining this leverage may be significant, will lower your returns, and may cause the Fund to lose money even if the value of ANT falls.
●Holding Period Risk - The performance of the Fund for periods longer than a single day will likely differ from the Daily Target. This difference may be significant. If you are considering holding fund shares for longer than a day, it's important that you understand the impact of ANT's returns and ANT's volatility (how much the value of ANT moves up and down from day-to-day) on your holding period return. ANT's volatility has a negative impact on Fund returns. During periods of higher volatility, ANT's volatility may affect the Fund's returns as much as or more than the return of ANT.
ANT commenced its IPO on November 19, 2026. As a result, there is a limited trading history for ANT and limited information is available regarding the impact of longer holding periods on returns. It's important that you understand that ANT has a limited trading history when considering whether to purchase shares or hold shares over time. Immediately following its IPO, ANT may experience abnormal returns and volatility. Such returns should not be expected to persist.
The following table illustrates the impact of ANT's volatility and ANT's return on Fund returns for a hypothetical one-year period. However, these effects will impact your return for any holding period other than a day. The longer
6 :: UltraShort Anthropic    
PROSHARES.COM
you hold shares of the Fund, the more magnified these effects will be. As a result, you should consider monitoring your investments in the Fund in light of your individual investment goals and risk tolerance.
In the table areas shaded darker represent those scenarios where the Fund can be expected to return less than the Daily Target. As the table shows, your return will tend to be worse than the Daily Target when there are smaller ANT price gains or losses and higher volatility in price of ANT. Your return will tend to be better than the Daily Target when there are larger ANT price gains or losses and lower volatility in the price of ANT. You may lose money when the return on ANT is flat (i.e., close to zero) and you may lose money when the price of ANT falls.
The table uses hypothetical annualized volatility in the price of ANT and return on ANT (derived from the first year of trading history of large-, mid-, and small-cap companies that completed an IPO between October 30, 2021 and October 30, 2026) to illustrate the impact of these two factors on Fund performance over a one-year period. It does not represent actual Fund returns, and was not derived from actual ANT returns (given its limited trading history). Each row corresponds to the level of a hypothetical return on ANT for a one-year period. Each column corresponds to a level of hypothetical annualized volatility of ANT. For example, the Fund may mistakenly be expected to achieve a -60% return if the annual returns on ANT were 30%. However, as the table shows, with a one-year return on ANT of 30% and an annualized volatility in the price of ANT of 100%, the Fund could be expected to return -97.1%. Actual returns and volatility for ANT over a one-year period could be substantially higher or lower than the figures presented in the table and could result in different Fund returns than those presented in the table.
The range of hypothetical annualized ANT volatility used in the table is especially high, reflecting the fact that the price of companies in the year following an IPO is historically highly volatile. Newly offered companies are often subject to extreme price volatility and speculative trading during and for a period of time after the IPO. Trading prices of ANT may experience significant volatility. Such volatility may persist. In light of this, you should carefully consider the significant negative impact of volatility on Fund returns and the potential for significant losses on your investment in the Fund, when considering whether to hold shares of the Fund for longer periods. 
Estimated Fund Returns
ANT Performance
One Year Volatility Rate
One
Year
ANT
Two times
the inverse
(-2x) of the
One Year
ANT
10%
25%
50%
75%
100%
-60%
120%
506.5%
418.1%
195.2%
15.6%
-68.9%
-50%
100%
288.2%
231.6%
88.9%
-26.0%
-80.1%
-40%
80%
169.6%
130.3%
31.2%
-48.6%
-86.2%
-30%
60%
98.1%
69.2%
-3.6%
-62.2%
-89.8%
-20%
40%
51.6%
29.5%
-26.2%
-71.1%
-92.2%
-10%
20%
19.8%
2.3%
-41.7%
-77.2%
-93.9%
0%
0%
-3.0%
-17.1%
-52.8%
-81.5%
-95.0%
10%
-20%
-19.8%
-31.5%
-61.0%
-84.7%
-95.9%
20%
-40%
-32.6%
-42.4%
-67.2%
-87.2%
-96.5%
30%
-60%
-42.6%
-50.9%
-72.0%
-89.1%
-97.1%
40%
-80%
-50.5%
-57.7%
-75.9%
-90.6%
-97.5%
50%
-100%
-56.9%
-63.2%
-79.0%
-91.8%
-97.8%
60%
-120%
-62.1%
-67.6%
-81.5%
-92.8%
-98.1%
Assumes: (a) no dividends paid with respect to ANT; (b) no Fund expenses; and (c) borrowing/lending rates (to obtain inverse leveraged exposure) of zero percent. The borrowing/lending rates to obtain inverse leveraged exposure are expected to be significant. If these were included the Fund's performance would be different from, and in some instances significantly lower than, that shown.
The average first-year annualized volatility rate for large-, mid-, and small-cap companies that completed an IPO between October 30, 2021 and October 30, 2026 was 81.25%. The highest first-year volatility rate among these companies was 348.74%. The average first-year total return performance for these companies was 15.96%. The lowest first-year total return performance for these companies was -99.97%. For more information and additional charts illustrating the effects of volatility and returns at higher rates of volatility, see "Special Considerations for a -2x Daily Objective Fund" in the Fund's Statement of Additional Information. The historical volatility and performance of large-, mid-, and small-cap companies in the first year following an IPO do not predict the future volatility and performance of ANT. Actual returns and volatility for ANT in the first year following its IPO could be substantially higher or lower. For more information, including additional graphs and charts demonstrating the effects of volatility and return on the long-term performance of the Fund, see "Understanding the Risks and Long-Term Performance of a -2x Daily Objective Fund" in the Fund's Prospectus.
   UltraShort Anthropic :: 7
PROSHARES.COM
●Correlation Risk - A number of factors may affect the Fund's ability to achieve a high degree of inverse leveraged correlation with the price of ANT. Fees, expenses, transaction costs, financing costs associated with the use of derivatives, among other factors, will adversely impact the Fund's ability to meet its Daily Target. In particular, the high financing costs associated with the Fund's inverse leveraged exposure to of ANT is expected to have a significant negative impact on the Fund's performance. In addition, if for any reason the Fund is unable to rebalance all or a portion of its investments, the Fund may have exposure to of ANT that is significantly greater or less than the Daily Target. Any of these factors may prevent the Fund from achieving exposure consistent with the Daily Target.
●Derivatives Risk - Investing in derivatives may be considered aggressive and may expose the Fund to greater risks including counterparty risk and correlation risk. The Fund may lose money if its derivatives do not perform as expected and may even lose money if they do perform as expected. Any costs associated with using derivatives will reduce the Fund's return. These costs are expected to be significant.
If the Fund's ability to obtain exposure to ANT consistent with its investment objective is disrupted for any reason, including for example, limited liquidity in the secondary market, a disruption in the secondary market, or as a result of margin requirements or capacity limits imposed by the Fund's counterparties, the Fund may not be able to achieve its investment objective and may experience significant losses. In such circumstances, the Advisor intends to take such action as it believes appropriate and in the best interest of the Fund. Any disruption in the Fund's ability to obtain inverse leveraged exposure to ANT will cause the Fund's performance to deviate from its investment objective. There is a heightened risk that the Fund will be unable to obtain exposure to ANT consistent with its investment objective immediately following the ANT IPO and for a period of time thereafter. Disruptions in the Fund's ability to obtain inverse leveraged exposure during this period will cause the Fund's performance to deviate from its investment objective.
○Swap Risk - Like all derivatives, the use of swaps may expose the Fund to greater counterparty risk and correlation risk. The terms of a swap agreement between the Fund and a counterparty may permit the counterparty to immediately close out the transaction with the Fund, including intraday (for example, if ANT has a dramatic intraday move that causes a material decline in the Fund's net assets). Such terminations may be more likely when the underlying asset is highly concentrated like ANT. If an agreement is terminated, the Fund may be unable to enter into another swap agreement or invest in other derivatives to achieve its investment objective. The Fund may be unable to find counterparties willing to
enter into swap agreements during periods of volatility in the price of ANT or other market conditions that may exist immediately following the ANT IPO and for a period of time thereafter. When the Fund invests in swaps that use ANT as the reference asset, the Fund will be subject to the risks of ANT.
●Counterparty Risk - The Fund may lose money if a counterparty does not meet its contractual obligations. Such losses may be significant. Counterparty defaults or bankruptcies may result in significant delays in payments and increased costs. Counterparty risk may increase during periods of financial market stress or when market liquidity is reduced. With respect to swap agreements, the terms of the agreement between the Fund and its counterparty may permit the counterparty to immediately close out the transaction with the Fund, including intraday (for example, if ANT has a dramatic intraday move that causes a material decline in the Fund's net assets). Such terminations may be more likely when the underlying asset is highly volatile and concentrated like ANT. If an agreement is terminated, the Fund may be unable to enter into another swap agreement or invest in other derivatives to achieve its investment objective.
●Liquidity Risk - The market for ANT is still developing and may be subject to periods of illiquidity. During such times it may be difficult or impossible to buy or sell a position at the desired price. Market disruptions or volatility can also make it difficult to find a counterparty willing to transact at a reasonable price and sufficient size. Illiquid markets may cause losses, which could be significant. The large size of the positions which the Fund may acquire increases the risk of illiquidity, may make its positions more difficult to liquidate, and may increase the losses incurred while trying to do so. Such large positions also may impact the price of ANT. During such periods of illiquidity, the Fund's shares could trade at a premium or discount to their net asset value and/or the bid-ask spread of the Fund's shares could widen. Under such circumstances, the Fund may be unable to rebalance its exposure properly which may result in significantly more or less exposure and losses to the Fund. In such an instance, the Fund may increase its transaction fee, change its investment objective, reduce its exposure or close.
●Equity and Market Risk - Equity markets are volatile, and the value of equity securities and other instruments correlated with equity markets may fluctuate dramatically from day to day. Equity markets are subject to corporate, political, regulatory, market, social, geopolitical and economic developments, including changes in interest and currency rates, inflation (or expectations for inflation), deflation (or expectations for deflation), global demand for particular products or resources, market instability, debt crises, embargoes, tariffs, sanctions and other trade barriers, regulatory
8 :: UltraShort Anthropic    
PROSHARES.COM
or governmental trade or market control programs, recessions, supply chain disruptions, labor disturbances, environmental or man-made disasters, war, terrorism, public health emergencies (such as the spread of infectious diseases, pandemics and epidemics), social unrest and other unforeseeable events.
●Money Market Instruments Risk - Adverse economic, political or market events affecting issuers of money market instruments, defaults by counterparties or changes in government regulations may have a negative impact on the performance of the Fund. The Fund's investments in money market instruments through an affiliated ETF are subject to the additional risk that the ETF's share price may fluctuate, including deviating from its net asset value during illiquid markets or during periods of high redemption activity.
●Industry Concentration Risk - The Fund's investment exposure is concentrated in the industry in which ANT operates. As a result, the Fund may be subject to greater market fluctuations than a fund that is more broadly invested across issuers and industries. As of October 30, 2026, ANT is included in the Information Technology industry group and, consequently, faces many of the same risks as other companies in that industry group.
○Information Technology Industry Risk - Companies in this industry may experience: intense competition, obsolescence of existing technology, and changing economic conditions and government regulation.
●Non-Diversification Risk - The Fund has the ability to invest its assets in the securities of a single issuer, (e.g., ANT) and in financial instruments with a single counterparty or a few counterparties. A rise in the price of ANT should be expected to result in a significant decline in the price of the Fund. This may increase the Fund's volatility and increase the risk that the Fund's performance will decline based on a single corporate, political, regulatory, market and economic event as compared to a more diversified portfolio of investments. In addition, the Fund's exposure to a single counterparty or a few counterparties may increase the risk that the Fund's performance will decline based on the credit of a single counterparty and that a material decline in the assets of the Fund will result in the termination of any swap agreements.
●Intraday Price Performance Risk - The intraday performance of Fund shares traded in the secondary market generally will be different from the performance of the Fund when measured from one NAV calculation-time to the next. When shares are bought intraday, the performance of the Fund's shares relative to ANT until the Fund's next NAV calculation time will generally be higher or lower than the Daily Target.
●Market Price Variance Risk - Investors buy and sell Fund shares in the secondary market at market prices. Market prices
may be different from the NAV per share of the Fund (i.e., the secondary market price may trade at a price greater than NAV (a premium) or less than NAV (a discount)). The market price of the Fund's shares will fluctuate in response to changes in the value of the Fund's holdings, supply and demand for shares and other market factors. There may be times when the market price and the NAV of the Fund's shares vary significantly, such as during periods of volatility in the price of ANT. Further, disruptions in the Fund's creation and redemption process, including during periods of significant volatility in the price of ANT, may result in market prices of the Fund that differ significantly from NAV. In times of severe market disruption or during after-hours trading, the bid-ask spread often increases significantly. Shares may trade at a discount to the value of the Fund's holdings, and the discount is likely to be greatest when the price of shares is falling fastest, which may be the time that you most want to sell your shares. These risks may be heightened immediately following the ANT IPO and for a period of time thereafter.
●Early Close/Late Close/Trading Halt Risk - An exchange or market may close early, close late or issue trading halts on ANT shares. A halt in trading of ANT is expected to result in a halt in the trading of the Fund's shares. In these circumstances, the Fund may be unable to rebalance its portfolio, may be unable to accurately price its investments and/or may incur substantial trading losses.
●Tax Risk - In order to qualify for the special tax treatment accorded a regulated investment company ("RIC") and its shareholders, the Fund must derive at least 90% of its gross income for each taxable year from "qualifying income," meet certain asset diversification tests at the end of each taxable quarter, and meet annual distribution requirements. The Fund's pursuit of its investment strategies will potentially be limited by the Fund's intention to qualify for such treatment and could adversely affect the Fund's ability to so qualify. The Fund may make certain investments, the treatment of which for these purposes is unclear. If, in any year, the Fund were to fail to qualify for the special tax treatment accorded a RIC and its shareholders, and were ineligible to or were not to cure such failure, the Fund would be taxed in the same manner as an ordinary corporation subject to U.S. federal income tax on all its income at the fund level. The resulting taxes could substantially reduce the Fund's net assets and the amount of income available for distribution. In addition, in order to requalify for taxation as a RIC, the Fund could be required to recognize unrealized gains, pay substantial taxes and interest, and make certain distributions. Please see the section entitled "Taxation" in the Statement of Additional Information for more information.
●New Fund Risk - The Fund has a limited operating history and started operations with a small asset base. There can be no assurance that the Fund will be successful or grow to
   UltraShort Anthropic :: 9
PROSHARES.COM
or maintain a viable size, that an active trading market for the Fund's shares will develop or be maintained, or that the Fund's shares' listing will continue unchanged.
Please see "Investment Objectives, Principal Investment Strategies and Related Risks" in the Fund's Prospectus for additional details.
Investment Results
Performance history will be available for the Fund after it has been in operation for a full calendar year. After the Fund has a full calendar year of performance information, performance information will be shown on an annual basis.
Management
The Fund is advised by ProShare Advisors. Alexander Ilyasov, Senior Portfolio Manager, and Eric Silverthorne, Portfolio Manager, have jointly and primarily managed the Fund since inception.
Purchase and Sale of Fund Shares
The Fund will issue and redeem shares only to Authorized Participants (typically broker-dealers) in exchange for the deposit or delivery of a basket of assets (securities and/or cash) in large blocks, known as Creation Units. Shares of the Fund may only be purchased and sold by retail investors in secondary
market transactions through broker-dealers or other financial intermediaries. Shares of the Fund are listed for trading on a national securities exchange and because shares trade at market prices rather than NAV, shares of the Fund may trade at a price greater than NAV (premium) or less than NAV (discount). In addition to brokerage commissions, investors incur the costs of the difference between the highest price a buyer is willing to pay to purchase shares of the Fund (bid) and the lowest price a seller is willing to accept for shares of the Fund (ask) when buying or selling shares in the secondary market (the "bid-ask spread"). The bid-ask spread varies over time for Fund shares based on trading volume and market liquidity. Recent information, including information about the Fund's NAV, market price, premiums and discounts, and bid-ask spreads, is included on the Fund's website (www.proshares.com).
Tax Information
Income and capital gains distributions you receive from the Fund generally are subject to federal income taxes and may also be subject to state and local taxes. The Fund intends to distribute income, if any, quarterly, and capital gains, if any, at least annually. Distributions for this Fund may be higher than those of most ETFs.
This page intentionally left blank.
This page intentionally left blank.
 
 
Investment Company Act file number 811-21114
ProShares Trust
7272 Wisconsin Avenue, 21st Floor, Bethesda, MD 20814
866.PRO.5125 866.776.5125
ProShares.com
 
© 2026 ProShare Advisors LLC. All rights reserved.ANTY-NOV26
ProShares Trust published this content on November 19, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 19, 2026 at 18:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]